A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

SHESHATSHIU, N.L. — Leaders in the Innu community of Sheshatshiu in Labrador have authorized barricades at the town's entrance and evicted some residents in an effort to curb the flow of drugs.

Further research revealed that one of these drugs, DDL-920 – developed at UCLA, led to the complete recovery of movement control – something many stroke patients never regain.

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that have taken the leap off the patent cliff. Big Pharma is staring down the ...

A handful of the drugs up for the second round of price cuts are made by companies that also participated in the first go around. The process resulted in substantial price reductions, including up ...

But that’s not the most shocking development this week ... who locked lips on their moonlit cruise during a drug-fueled bender, urged onward by Chelsea (Aimee Lou Wood) and Chloe (Charlotte ...

“Let’s look at a typical duration of a drug from start to launch: 10 to 12 years. Process development takes one to 1.5 to two years. And if we can basically speed up here the workflows ...

Despite the time and money invested by biotech and pharma companies in the drug development process, statistics show that 90% of drugs fail in clinical trials. This is usually because they do not meet ...

Media outlets have referred to Akeso’s cancer drug development as the Chinese biotech industry’s “DeepSeek moment”. Last month, Chinese start-up DeepSeek shocked the global tech industry ...

MANILA – Chief Presidential Legal Counsel Juan Ponce Enrile emphasized the importance of due process, asserting that all individuals, including drug suspects, are entitled to legal protections. “Under ...

The model provides quantitative insights into how different inhibitors impact cellular pathways, offering a new way to generate hypotheses and refine drug development strategies. “From a big pharma ...